Skip to content
Open Data Finder
Open Government Canada

Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Risk of Abnormal Heart Rhythm

Published by Health Canada | Santé Canada

About this dataset

A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use of hydroxyzine products could be associated with abnormal changes in the electrical activity of the heart, such as QT interval prolongation.

Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Ris… · Open Data Finder